We Need To Rethink Hormone Replacement In Women

A recent Danish study shows that 10 years of hormone replacement started early in menopause significantly improved cardiovascular risk (50% reduction).  A few years ago America was floored by the Women’s Health Initiative’s results which suggested no cardiovascular benefit and an additional cost of increased breast cancer risk. That information caused the doctors and patients to make an about-face and withdraw all hormone replacement as well as not offer any replacement when menopause started. This 10 year treatment trial with an additional 6 years of followup show no demonstrable increase in cancer but a 50% drop in cardiovascular rates.  I recommend readers read a more detailed newsletter from HeartWire for more details.

In my practice over the years I have noticed that the women who took early and persistent hormone replacement appeared more youthful than their counterparts. Anecdotely I have also noticed that in whenever I occasionally note a women’t bone density is far better then predicted, the patient started hormone replacement early in their menopause history.

Bottom Line:  This study is going to put a monkey-wrench in the gynecology recommendations about hormone replacement. Women’s doctors are going to have to rethink the recent past reflex”legal concerned”  about face decision to not provide hormone replacement and consider quality of life as well as perhaps the unrecognized health benefits of early hormone replacement in women going through menopause.  This study was powered enough to provide meaningful information albeit it was far smaller than the Women’s Health Initiative.

About thedoctorsreport

Dr. Kordonowy is board certified by the American Board of Internal Medicine and has been in private practice since 1993. His group practice is in Fort Myers, Florida. His website is: www.drkordonowy.com. He earned his degree from the University of Kansas School of Medicine in Kansas City, Kansas and completed his residency as Chief Resident at Orlando Regional Hospital System. As Chief Resident, Dr. Kordonowy was recognized as the Outstanding Resident by the American College of Physicians. He is a member of the American Medical Association, American College of Physicians, and the American Society of Internal Medicine. In December 2005, Dr. Kordonowy became Board Certified in the new field of Clinical Lipidology by the American Board of Clinical Lipidology. Lipidology is the specialty of diagnosis and management of cholesterol and triglyceride metabolism disorders. Cardiovascular disease risk assessment is also part of this specialty. He now serves as president of the Independent Physicians Association of Lee County. He is active in the Lee County Medical Society, the Florida Medical Society , the Florida Lipid Foundation, National Lipid Association and the American Medical Association.
This entry was posted in Articles, Medical Journal Briefs, News and tagged , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s